EUVIMEDEUVIMED entdecken
Open Access

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data

Huseyin Kara, Ali Erdogan

Dusunen Adam: Journal of Psychiatry and Neurological Sciences · 2026 · 52-58

DOI: 10.14744/dajpns.2026.00314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dusunen Adam: Journal of Psychiatry and Neurological Sciences, 2026. Verfasst von Huseyin Kara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Practice, Antalya, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Brexpiprazoleanxietydepressionfunctioningtreatment-resistant depression

Autor:innen und Institutionen

  • Private Practice, Antalya, Turkiye.
  • Akdeniz University Faculty of Medicine, Department of Psychiatry, Antalya, Turkiye.

Zitieren

APA

Kara, H., & Erdogan, A. (2026). Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data. Dusunen Adam: Journal of Psychiatry and Neurological Sciences, 52-58. https://doi.org/10.14744/dajpns.2026.00314

Vancouver

Kara H, Erdogan A. Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data. Dusunen Adam: Journal of Psychiatry and Neurological Sciences. 2026:52-58. doi:10.14744/dajpns.2026.00314

BibTeX
@article{Kara2026,
  author = {Kara, Huseyin and Erdogan, Ali},
  title = {Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data},
  journal = {Dusunen Adam: Journal of Psychiatry and Neurological Sciences},
  year = {2026},
  pages = {52--58},
  doi = {10.14744/dajpns.2026.00314}
}
Kostenlos starten →